Treatment

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc bibendum commodo odio, eu pretium massa dignissim id. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Sed euismod, massa sit amet tincidunt tempor, orci ante placerat dui, eget pellentesque ex mauris porta sem. Nullam consectetur arcu libero, accumsan faucibus quam iaculis eget. Nulla molestie, erat vel convallis convallis, libero quam auctor justo, quis consectetur nibh arcu ut sem. Etiam consectetur, nunc sed imperdiet sodales, massa leo consequat ante, ac commodo erat quam in metus. Sed vitae efficitur arcu. Phasellus nec dui elit. Duis dignissim, erat sit amet condimentum commodo, risus ligula tempor tortor, non hendrerit lorem augue eu libero.

Curabitur mi lorem, egestas nec risus in, scelerisque placerat mauris. Phasellus in felis ullamcorper quam ullamcorper maximus vel et lectus. Integer varius ex mattis mauris volutpat scelerisque. Nullam eleifend eros et eros placerat congue. Sed eu dui cursus, mattis ipsum in, consectetur lectus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Integer vitae fermentum lacus. Quisque in auctor sem. Nunc fringilla suscipit turpis, ut vulputate lacus vehicula eu. In tristique nunc sit amet facilisis finibus. Nulla tortor ante, fringilla at tortor ut, faucibus commodo risus. Aliquam placerat id lectus at pretium.


Key Insights

  • To eliminate HIV transmission by 2025, 98% of all people diagnosed with HIV must be taking cART, and 98% of people on cART must be virologically suppressed.
  • To eliminate HIV transmission, Australia must provide free clinical care, laboratory monitoring and cART to all PLHIV in Australia, irrespective of their visa or residency status.
  • To optimise health, quality of life, retention in care and prevention of HIV transmission, national programs involving clinicians, pharmacists, community-based organisations and peers must be funded so 90% of all people diagnosed with HIV can commence cART, ideally on the same day as diagnosis, but no later than 14 days after diagnosis.
  • Upcoming novel antiretroviral treatments must receive priority evaluation for TGA registration and PBS subsidisation to enhance treatment uptake and sustained use by PLHIV.

Renewing Targets

The relationship between the metrics of the HIV Care Cascade and the elimination of HIV transmission is complex and will vary between countries and within jurisdictions of individual countries.

Proposed treatment targets required to achieve the elimination of HIV transmission in Australia by 2025

  1. 98% of all people diagnosed with HIV will be on cART.
  2. 98% of people on cART will be virologically suppressed.
  3. 90% of all people diagnosed with HIV will commence cART, ideally on the day of diagnosis, but no later than 14 days from diagnosis.

Priorities

Priorities with respect to HIV treatment and the achievement of elimination of HIB transmission

  • Obtain federal and jurisdictional funding commitments to provide free clinical care, laboratory monitoring and cART for all people diagnosed with HIV in Australia, irrespective of their visa or residency status.
  • Create national programs enabling people newly diagnosed with HIV to commence rapid cART.
  • Double the number of S100 prescribers in Australia from 500 to 1,000 by 2025, and increase reimbursements for all MBS items related to the treatment and care of people diagnosed with HIV in Australia.
  • Remove all barriers preventing the TGA and the Pharmaceutical Benefits Advisory Committee from calling for submissions for priority evaluation of novel HIV treatments for registration and subsidisation.
  • Increase funding for surveillance and research into cART uptake, ongoing cART use and HIV virological suppression in all HIV priority populations in Australia, irrespective of visa or residency status.